Abstract
Human leukocyte interferon has been produced for clinical use in our laboratories for several years (1). A routine procedure for the production and purification has been established (2,3), but studies to improve the recovery and quality of the clinical interferon continue. Since the availability of fresh leukocytes is the factor limiting production, maximization of the interferon yield per blood unit is of prime importance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cantell, K., Hirvon, S., Mogensen, K.E., and Pyhälä, L. In: In Vitro, Ed. C. Waymouth. The Tissue Culture Association, Rockville, 1974, pp. 35–38.
Cantell, K., and Hirvonen, S. Texas Rep. Biol. Med., In press.
Mogensen, K. E., and Cantell, K. Pharmacology and Therapeutis, In press.
Tenczar, F. J. Transfusion 13: 183, 1973.
Shinkai, K., and Nishimura, T. Japan. J. Microbiol. 20: 251, 1976.
Strander, H., Cantell, K., Carlström, G., and Jacobson, P. J. Nat. Cancer Inst. 51: 733, 1973.
Weeke, B. Scand. J. Immunol., Vol. 2, Suppl. 1, 1973, pp. 47.
Strander, H., and Cantell, K. Ann. Med. Exp. Fenn. 44: 265, 1966.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1978 Plenum Press, New York
About this chapter
Cite this chapter
Kauppinen, HL., Myllylä, G., Cantell, K. (1978). Large Scale Production and Properties of Human Leukocyte Interferon Used in Clinical Trials. In: Stinebring, W.R., Chapple, P.J. (eds) Human Interferon. Advances in Experimental Medicine and Biology, vol 110. Springer, New York, NY. https://doi.org/10.1007/978-1-4615-9080-4_1
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9080-4_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4615-9082-8
Online ISBN: 978-1-4615-9080-4
eBook Packages: Springer Book Archive